END-ZIT

Dosage form: lotion, augmented
Ingredients: SULFUR .05g in 1mL
Labeler: ABBE Laboratories, Inc.
NDC Code: 68605-2001

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

END-ZIT® ACNE CONTROL DRYING LOTION

Intended for use on blemishes only. This advanced formulation is designed to dry and aid in elimination of pimples. It is make-up quality for excellent coverage of the blemish. It is unbelievably effective, clinically tested, dermatologist approved and recommended.

DIRECTIONS: Shake bottle well before each use. Apply directly to blemish only, using applicator. Wait a few moments until slightly dry. Pat with fingertip or clean cotton swab to blend color to skin. Make-up may be applied if desired. Should remain on skin all day. Re-apply at night to clean skin to remain on skin overnight.

NOTE: PERSONS WITH KNOWN SENSITIVITY TO SULFUR SHOULD AVOID USE OF THIS PRODUCT.
KEEP FROM EYES.

DRUG  FACTS
ACTIVE INGREDIENT ............  SULFUR 5%

PURPOSE    .............    ACNE TREATMENT

WARNINGS:
• For external use only.
• Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
• Do not get into eyes. If excessive skin irritation deve lops or increases, discontinue use and consult a doctor.

• Keep out of reach of children.

OTHER INGREDIENTS: Isopropyl Alcohol, Water, Zinc Oxide, Propylene Glycol, Camphor, Talc, Sodium Laureth Sulfate, Titanium Dioxide, Diazolidinyl Urea, Methylparaben, Propylparaben. May contain Iron Oxides.

NDC #'s
Light/Medium 68605-2001-2       Medium/Dark 68605-2002-2
Sun Bronze 68605-2003-2                  Untinted 68605-2006-2

DIRECTIONS: SHAKE BOTTLE WELL.
APPLY TWICE DAILY DIRECTLY TO
ACNE BREAKOUT. ALLOW TO DRY
FOR 10 SECONDS. PAT TO BLEND.
APPLY MAKE-UP IF DESIRED.

ACTIVE INGREDIENT: SULFUR 5%.

WARNINGS:
AVOID IF ALLERGIC TO SULFUR
AVOID CONTACT WITH EYES
FOR EXTERNAL USE ONLY
KEEP FROM CHILDREN

Manufactured by ABBE Laboratories, Inc.
Farmingdale, NY 11735
Made in the U.S.A.

END-ZIT®

ACNE CONTROL
DRYING LOTION

ABBE

0.62 OZ. (17.57 g)

END-ZIT 
sulfur lotion, augmented
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68605-2001
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (SULFUR) SULFUR.05 g  in 1 mL
Inactive Ingredients
Ingredient NameStrength
ISOPROPYL ALCOHOL 
WATER 
ZINC OXIDE 
PROPYLENE GLYCOL 
CAMPHOR (SYNTHETIC) 
TALC 
SODIUM LAURETH SULFATE 
TITANIUM DIOXIDE 
DIAZOLIDINYL UREA 
METHYLPARABEN 
PROPYLPARABEN 
Product Characteristics
Colorbrown (Light/Medium) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:68605-2001-214.78 mL in 1 BOTTLE, GLASS
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D04/20/2004
END-ZIT 
sulfur lotion, augmented
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68605-2002
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (SULFUR) SULFUR.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
ISOPROPYL ALCOHOL 
WATER 
ZINC OXIDE 
PROPYLENE GLYCOL 
CAMPHOR (SYNTHETIC) 
TALC 
SODIUM LAURETH SULFATE 
TITANIUM DIOXIDE 
DIAZOLIDINYL UREA 
METHYLPARABEN 
PROPYLPARABEN 
Product Characteristics
Colorbrown (Medium/Dark) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:68605-2002-217.57 g in 1 BOTTLE, GLASS
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D04/20/2004
END-ZIT 
sulfur lotion, augmented
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68605-2003
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (SULFUR) SULFUR.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
ISOPROPYL ALCOHOL 
WATER 
ZINC OXIDE 
PROPYLENE GLYCOL 
CAMPHOR (SYNTHETIC) 
TALC 
SODIUM LAURETH SULFATE 
TITANIUM DIOXIDE 
DIAZOLIDINYL UREA 
METHYLPARABEN 
PROPYLPARABEN 
Product Characteristics
Colorbrown (Sun Bronze) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:68605-2003-217.57 g in 1 BOTTLE, GLASS
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D04/20/2004
END-ZIT 
sulfur lotion, augmented
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68605-2006
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFUR (SULFUR) SULFUR.05 g  in 1 g
Inactive Ingredients
Ingredient NameStrength
ISOPROPYL ALCOHOL 
WATER 
ZINC OXIDE 
PROPYLENE GLYCOL 
CAMPHOR (SYNTHETIC) 
TALC 
SODIUM LAURETH SULFATE 
TITANIUM DIOXIDE 
DIAZOLIDINYL UREA 
METHYLPARABEN 
PROPYLPARABEN 
Product Characteristics
Colorwhite (Untinted) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage Description
1NDC:68605-2006-217.57 g in 1 BOTTLE, GLASS
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D04/20/2004
Labeler - ABBE Laboratories, Inc. (781745286)
Establishment
NameAddressID/FEIOperations
ABBE Laboratories, Inc.781745286manufacture

Revised: 03/2011
 
ABBE Laboratories, Inc.

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)